IGFBP-2, His, Mouse
IGFBP-2, His, Mouse

The purity of IGFBP-2, His, Mouse is greater than 95% as determined by SEC-HPLC.

IGFBP-2, His, Mouse

IGFBP-2, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

IGFBP-2, His, Mouse

Insulin-like growth factor (IGF) binding protein 2 (IGFBP2) was discovered and identified as an IGF system regulator, controlling the distribution, function, and activity of IGFs in the pericellular space. IGFBP2 is a developmentally regulated gene that is highly expressed in embryonic and fetal tissues and markedly decreases after birth.IGFBP2 is upregulated and promotes several key oncogenic processes, such as epithelial-to-mesenchymal transition, cellular migration, invasion, angiogenesis, stemness, transcriptional activation, and epigenetic programming via signaling that is often independent of IGFs.
Z06173
¥63,425.00

Ask us a question
Product Introduction
Species Mouse
Protein Construction
IGFBP-2 (Glu35-Gln305)_x000D_
Accession # P47877		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 30.6 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 32-40 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • IGFBP-2, His, Mouse
    • IGFBP-2, His, Mouse

    The purity of IGFBP-2, His, Mouse is greater than 95% as determined by SEC-HPLC.

  • IGFBP-2, His, Mouse
    • IGFBP-2, His, Mouse

    IGFBP-2, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Insulin-like growth factor (IGF) binding protein 2 (IGFBP2) was discovered and identified as an IGF system regulator, controlling the distribution, function, and activity of IGFs in the pericellular space. IGFBP2 is a developmentally regulated gene that is highly expressed in embryonic and fetal tissues and markedly decreases after birth.IGFBP2 is upregulated and promotes several key oncogenic processes, such as epithelial-to-mesenchymal transition, cellular migration, invasion, angiogenesis, stemness, transcriptional activation, and epigenetic programming via signaling that is often independent of IGFs.
Synonyms IBP-2; IGFBP-2; BP2; AI255832; mIGFBP-2; IGFBP2; IGF-BP53

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.